Rights and permissions
About this article
Cite this article
FDA use of advisory committees not optimum. Inpharma Wkly. 1570, 2 (2007). https://doi.org/10.2165/00128413-200715700-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715700-00002